BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 24, 2026
Home
»
Newsletters
» BioWorld
BioWorld
Dec. 6, 2007
View Archived Issues
Adolor Inks $265M Deal With Pfizer For Opioid
Adolor Corp.'s beleaguered shares got a 20 percent boost on Wednesday after the company announced a $265 million deal with Pfizer Inc. for the delta opioid agonists ADL5859 and ADL5747. (BioWorld Today)
Read More
Amarin Obtains MRNA Platform, Phase II Drug Via Acquisition
Read More
Bone Marrow Contributor To Tumor Vessel Growth Found
Read More
FDA Panel Votes Against Avastin Use For Breast Cancer Patients
Read More
United Kills Cancer Program Following Pivotal Trial Failures
Read More
Other News To Note
Read More
Clinic Roundup
Read More
